MedPro Safety Products launches automatic hypodermic safety syringe

NewsGuard 100/100 Score

MedPro Safety Products, Inc. (OTCBB:MPSP), a leading developer of transformational technologies that enable safer medication delivery and blood collection, today announced the introduction of its hypodermic safety syringe. The device incorporates a proprietary safety shield that is automatically released during the administration of medicine, covering the needle as it is removed, and thereby enhancing patient and operator safety.

“The passive hypodermic safety syringe is the latest offering in our efforts to expand our patented passive safety technology across a broad range of products”

The passive (automatic) hypodermic safety syringe provides unique features and benefits. The passive safety mechanism is integrated into the syringe and is activated through the normal process of medication delivery. The shield is automatically deployed over the contaminated needle, reducing the chances of a needlestick injury. It prevents recapping, removal and reuse of the syringe with the engagements of its auto-disable feature and reduces the chance of blood or drug splatter. The device is easy to use and provides an unobstructed view of the patient during an injection.

"The passive hypodermic safety syringe is the latest offering in our efforts to expand our patented passive safety technology across a broad range of products," said Craig Turner, CEO of MedPro Safety Products. "This development demonstrates the strength of our research and development effort. We are in various stages of discussions with several potential partners to explore the commercialization of the hypodermic safety syringe and we will be featuring this new product at the Annual APIC Conference in Baltimore running from June 27 through June 29."

SOURCE MedPro Safety Products, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study highlights anti-inflammatory properties of herbal medicine, Erigeron breviscapus to treat osteoarthritis